|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,096.00 JPY | +3.73% |
|
+0.01% | -1.78% |
| 11/05 | Jefferies Adjusts Chugai Pharmaceutical's Price Target to 8,500 Yen from 9,100 Yen, Keeps at Hold | MT |
| 07/05 | Japan's Nikkei blazes past 63,000 on earnings, Iran peace optimism; JGBs rally | RE |
| Capitalization | 12,845B 81.37B 69.49B 63.67B 60.19B 111B 7,788B 112B 758B 295B 3,696B 305B 299B | P/E ratio 2026 * |
25.2x | P/E ratio 2027 * | 21.8x |
|---|---|---|---|---|---|
| Enterprise value | 11,875B 75.22B 64.24B 58.86B 55.65B 103B 7,199B 104B 701B 273B 3,416B 282B 276B | EV / Sales 2026 * |
8.59x | EV / Sales 2027 * | 7.64x |
| Free-Float |
38.12% | Yield 2026 * |
1.75% | Yield 2027 * | 1.98% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | +3.73% | ||
| 1 week | +0.01% | ||
| Current month | -0.25% | ||
| 1 month | -4.98% | ||
| 3 months | -12.78% | ||
| 6 months | -0.21% | ||
| Current year | -1.78% |
| 1 week | 7,691 | 8,248 | |
| 1 month | 7,402 | 9,013 | |
| Current year | 7,402 | 10,700 | |
| 1 year | 5,942 | 10,700 | |
| 3 years | 3,580 | 10,700 | |
| 5 years | 3,191 | 10,700 | |
| 10 years | 1,003.33 | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 01/01/2021 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | - | 28/03/2024 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Motoo Ueno
BRD | Director/Board Member | 68 | 01/03/1993 |
Masayuki Oku
BRD | Director/Board Member | 81 | 01/03/2015 |
| Director/Board Member | 77 | 01/03/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.73% | +0.01% | +7.95% | +124.08% | 81.37B | ||
| +2.61% | +2.91% | +36.15% | +133.81% | 906B | ||
| +2.75% | +2.58% | +55.23% | +43.31% | 555B | ||
| +0.31% | +1.69% | +10.90% | +41.69% | 368B | ||
| -0.94% | -2.05% | +21.74% | +10.73% | 326B | ||
| +0.59% | +4.06% | +38.24% | +15.45% | 289B | ||
| +0.78% | +1.00% | +29.63% | +26.23% | 285B | ||
| +0.96% | -0.10% | +48.05% | -3.15% | 280B | ||
| +0.91% | +2.12% | -31.78% | -49.10% | 208B | ||
| +0.05% | +1.61% | +24.40% | +44.43% | 182B | ||
| Average | +0.63% | +0.44% | +24.05% | +38.75% | 347.98B | |
| Weighted average by Cap. | +0.37% | +1.09% | +30.43% | +52.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,382B 8.76B 7.48B 6.85B 6.48B 11.99B 838B 12.06B 81.58B 31.76B 398B 32.85B 32.16B | 1,521B 9.64B 8.23B 7.54B 7.13B 13.2B 922B 13.27B 89.79B 34.96B 438B 36.16B 35.4B |
| Net income | 511B 3.23B 2.76B 2.53B 2.39B 4.43B 310B 4.45B 30.13B 11.73B 147B 12.13B 11.88B | 589B 3.73B 3.19B 2.92B 2.76B 5.11B 357B 5.14B 34.75B 13.53B 169B 13.99B 13.7B |
| Net Debt | -970B -6.15B -5.25B -4.81B -4.55B -8.42B -588B -8.46B -57.27B -22.29B -279B -23.06B -22.58B | -1,226B -7.77B -6.63B -6.08B -5.75B -10.64B -743B -10.7B -72.37B -28.18B -353B -29.15B -28.54B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/05/26 | 8,096.00 ¥ | +3.73% | 2,811,500 |
| 13/05/26 | 7,805.00 ¥ | +0.14% | 2,385,200 |
| 12/05/26 | 7,794.00 ¥ | -2.00% | 2,123,700 |
| 11/05/26 | 7,953.00 ¥ | +0.67% | 3,038,800 |
| 08/05/26 | 7,900.00 ¥ | -2.41% | 4,228,200 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















